학술논문
Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial: Lipid-lowering efficacy and safety of alirocumab in individuals with type 2 diabetes and mixed dyslipidaemia at high cardiovascular risk
Document Type
Article
Author
Source
In: Cardiovascular Diabetology . (Cardiovascular Diabetology, 25 May 2017, 16(1))
Subject
Language
English
ISSN
14752840